We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

altona Diagnostics GmbH

altona Diagnostics GmbH develops and commercializes real-time PCR based assays and molecular diagnostic test solution... read more Featured Products: More products

Download Mobile App

Altona Diagnostics Exhibits AltoStar Product Range at ECCMID 2022

By LabMedica International staff writers
Posted on 22 Apr 2022
Print article
Image: AltoStar Automation System AM16 robotic pipetting workstation (Photo courtesy of altona Diagnostics)
Image: AltoStar Automation System AM16 robotic pipetting workstation (Photo courtesy of altona Diagnostics)

Altona Diagnostics GmbH (Hamburg, Germany) exhibited its AltoStar product line of automated real-time PCR testing solutions suitable for high-throughput laboratories at ECCMID 2022. The event brought together the best and brightest in the field of clinical microbiology and infectious diseases from all over the world.

The flexible and efficient AltoStar Molecular Diagnostic Workflow automates your PCR analyses from sample extraction to PCR results and enables full traceability. At ECCMID 2022, altona demonstrated the AltoStar Automation System AM16, a pipetting workstation, in combination with the AltoStar Connect software, is the centerpiece of the AltoStar Workflow. It is intended to be used in combination with the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and altona Diagnostics PCR kits for automated purification of nucleic acids and automated assay setup for in vitro diagnostic purposes.

The AltoStar Connect software used to operate the AltoStar Automation System AM16 is a time-saving state-of-the-art application software that provides loading dialogue to guide through each loading step in order to ensure the completeness of the set up procedure. It can be connected to one or several real-time PCR instruments for their automatic programming and allows sample information and worklist to be imported via barcode reader or LIMS. It features predefined purification protocols and offers automated selection of controls and standards.

In addition, altona presented the AltoStar reagents that are altona Diagnostics-specific products, which are part of the workflow based on AltoStar AM16 and AltoStar Connect software. The AltoStar PCR kits are based on real-time PCR technology, utilizing PCR for amplification of specified target sequences and target-specific probes in order to detect amplified DNA or RNA. The AltoStar Purification Kit 1.5 uses magnetic particle technology and is intended to be used for automated isolation and purification of nucleic acids from specified human specimens for in vitro diagnostic purposes. It permits simultaneous purification of RNA and DNA from multiple sample types. The AltoStar Internal Control 1.5 is intended to be used as a nucleic acid extraction, amplification and detection control for in vitro diagnostic purposes. The control contains the internal purification control and is added at the beginning of the purification procedure. All tubes and containers of the AltoStar Purification Kit 1.5, the AltoStar Internal Control 1.5 and the AltoStar PCR Kit 1.5 are barcoded by the AltoStar system for automated identification, localization and verification of lot conformity, as well as non-expiry.

Related Links:
altona Diagnostics GmbH 

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Clinical Chemistry

view channel
Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)

New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections

Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read more

Molecular Diagnostics

view channel
Image: The new tests seek to detect mutant DNA in blood samples, indicating the presence of cancer cells (Photo courtesy of Christian Stolte/Weill Cornell)

Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods

Liquid biopsy technology has yet to fully deliver on its significant potential. Traditional methods have focused on a narrow range of cancer-associated mutations that are often present in such low quantities... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)

Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing

Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.